Johnson & Johnson (JNJ):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7395
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:280
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Johnson & Johnson (J&J) researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson (JNJ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 8
List of Figures 10
Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12
Johnson & Johnson, Medical Equipment Deals By Type, 2012 to YTD 2018 13
Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14
Johnson & Johnson, Medical Equipment, Deals By Market, 2012 to YTD 2018 15
Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 17
Johnson & Johnson, Medical Equipment, Deal Details 31
Asset Purchase 31
Johnson & Johnson May Sell its Sterilization Products Division for up to USD2 Billion 31
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 32
Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 33
Venture Financing 34
OrthoSpin Raises USD3 Million in Financing 34
Cue Health Raises USD45 Million in Series B Venture Financing 35
Zebra Medical Vision Raises USD30 Million in Series C Financing 37
NeuroVision Imaging Raises USD11.2 Million in Series C Venture Financing 38
V-Wave Raises USD70 Million in Series C Financing 40
RefleXion Medical Raises USD100 Million in Series C Financing 42
DayTwo Raises USD12 Million in Series A Financing 44
Hyalex Orthopaedics Raises USD16 Million in Series A Financing 45
CartiHeal Raises USD18.3 Million in Venture Financing 46
Grail Raises USD914 Million in First Tranche of Series B Financing 47
Atlas Genetics Raises USD35 Million in Series D Financing 50
OrthoSpace Raises USD7 Million in Venture Financing 52
ReVision Optics Raises USD32 Million in Venture Financing 53
CVRx Raises USD57.7 Million in Series G Financing 55
RefleXion Medical Raises Additional USD6 Million in Series B Financing 57
WellDoc Raises USD7.5 Million in Extended Series B Financing 58
Cala Health Raises USD18 Million in Series A Financing Round 59
Inivata Raises USD45 Million in Series A Financing 61
V-Wave Raises USD28 Million in Venture Financing 63
CartiHeal Raises USD15 Million in Venture Financing Round 64
Atlas Genetics Raises USD20 Million in Series C Financing 65
La Lumiere Raises USD20 Million in Series B Venture Financing 67
NeuWave Medical Raises USD4.76 Million in Venture Financing 68
Inivata Raises USD6.5 Million in Venture Financing 69
Biocartis Raises USD85 Million in Venture Financing 70
PowerVision Raises USD30 Million in Series D Financing 71
Inspire Medical Systems Raises USD40 Million In Series E Financing 73
Torax Medical Raises US$13.7 Million In Venture Financing 75
Biocartis Raises US$40.5 Million In Series E Financing 76
CVRx Raises US$42 Million In Series F Financing 78
ReVision Optics Raises US$55 Million In Venture Financing 80
Cardiac Dimensions Raises US$2.4 Million In Venture Financing 82
Nevro Raises US$48 Million In Series C Financing 84
Biocartis Raises US$44.7 Million In Series D Financing 86
Torax Medical Raises US$30 Million In Series D Financing 88
NeuWave Medical Raises US$14 Million In Series B Financing 90
Astute Medical Raises US$40.4 Million In Series C Financing 91
Mitralign Raises US$35 Million In Series D Financing 93
Direct Flow Medical Secures USD0.28 Million in Venture Funding 95
Coherex Medical Secures USD16.5 Million in Venture Funding 96
PowerVision Raises Additional US$12.5 Million In Series C Venture Financing 97
Pronota Raises US$4.8 Million In Series C Financing 99
Clarimedix Raises Financing From COSAT 101
Private Equity 102
Platinum Equity Acquires LifeScan from Johnson & Johnson for USD2.1 Billion 102
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 103
Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 105
Partnerships 107
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 107
Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 108
KFx Medical Enters into Licensing Agreement with DePuy Mitek 109
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 110
Auris Health Enters into Agreement with NeuWave Medical 111
Fujirebio Enters into Agreement with Janssen Pharma 112
Johnson & Johnson Innovation and Johnson & Johnson Vision Care Enter into Partnership with Queensland University of Technology 113
Johnson & Johnson Innovation, Janssen Cilag Enter into Partnership with Queensland University of Technology 114
Johnson & Johnson Innovation and Janssen Pharma Enter into Partnership with MiRXES 115
Johnson & Johnson Vision Care Enters into Partnership with Narayana Nethralaya 116
Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with MiNDERA 117
Genomic Health Enters into Research Agreement with Janssen Pharma 118
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 119
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 120
Adaptive Biotech Enters into Partnership with Janssen Biotech 121
Sebia Enters into Agreement with Janssen Biotech 122
Johnson & Johnson Enters into Research Agreement with Orthocell 123
Rest Devices Enters into Agreement with Johnson & Johnson Consumer 124
Aspect Biosystems Partners with DePuy Synthes 125
Karolinska Institutet Partners with Johnson & Johnson Companies 126
WellDoc Enters into Agreement with LifeScan 127
Codman Neuro Enters into Distribution Agreement with InNeuroCo 128
Materialise Enters into Distribution Agreement with DePuy Synthes 129
Johnson & Johnson Services Partners with HP 130
LifeScan Enters into Agreement with WellDoc 131
Biosense Webster Enters into Agreement with Northwestern University 132
Medos International Enters into Agreement with Rainbow Medical 133
Ethicon Endo-Surgery Enters into Agreement with HistoSonics 134
Janssen Pharma Enters into Agreement with Cue 135
Johnson & Johnson Forms Joint Venture with Google Life Sciences 136
DePuy Synthes Enters into Agreement with Radlink 138
Royal Philips Enters into Co-Development Agreement with Janssen Pharma 139
Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 140
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 141
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 142
Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 143
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 144
Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 145
BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 146
Janssen Research & Development Enters into Research Agreement with MD Biosciences 147
DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 148
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 149
Myriad Enters Into Research Agreement With Janssen Research & Development 150
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 151
Coherex Medical Enters Into Distribution Agreement With Biosense Webster 152
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 153
Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 154
OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 155
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 156
Philips Enters Into Technology Integration Agreement With Biosense Webster 157
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 158
Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 159
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 160
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 161
Insulet Enters Into Technology Integration Agreement With LifeScan 162
Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 163
Equity Offering 164
Sphere Medical Completes Private Placement Of Shares For US$5 Million With Johnson & Johnson 164
Debt Offering 165
Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 165
Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 167
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 169
Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 171
Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 173
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 175
Asset Transactions 177
CeQur Acquires Assets from Calibra Medical 177
Syncona Acquires Surgical Platform from Janssen Biotech 178
Sinocare May Acquire Diabetes Care Business from Johnson & Johnson for up to USD4 Billion 179
Centinel Spine Acquires Prodisc Assets from DePuy Synthes 180
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 181
Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 183
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 184
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 185
Acquisition 186
Johnson & Johnson Medical Acquires Emerging Implant Technologies from SHS Gesellschaft 186
Fortive to Acquire Advanced Sterilization Products from Ethicon US for USD2.8 Billion 187
Apsis Acquires Orthotaxy 189
Johnson & Johnson Medical to Acquire Surgical Process Institute 190
Johnson & Johnson Acquires Sightbox 191
Abbott Medical Optics Acquires TearScience 192
Johnson & Johnson Acquires Actelion for USD30 Billion 193
Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 195
Codman Neuro Acquires Neuravi 197
Ethicon Acquires Torax Medical 198
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 199
Ethicon Endo-Surgery Acquires Megadyne Medical Products 201
Codman Neuro Acquires Pulsar Vascular 202
DePuy Orthopaedics Acquires BioMedical Enterprises 203
Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 204
Johnson & Johnson May Acquire Transenterix 206
Johnson & Johnson Consumer Acquires La Lumiere 207
Biosense Webster Acquires Coherex Medical 208
Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 209
DePuy Synthes Acquires Olive Medical 211
Johnson & Johnson Plans to Acquire Cardiovascular Company 212
ZOLL Medical Acquires CoAxia, Medical Device Company 213
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 215
Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 217
LifeScan Acquires Calibra Medical 218
Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 219
Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 221
Johnson & Johnson – Key Competitors 222
Johnson & Johnson – Key Employees 223
Johnson & Johnson – Locations And Subsidiaries 224
Head Office 224
Other Locations & Subsidiaries 224
Recent Developments 243
Strategy And Business Planning 243
Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for $2.1bn 243
Financial Announcements 244
Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results 244
Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 246
Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 248
Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results 250
Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 252
Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 254
Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 256
Apr 18, 2017: Johnson & Johnson Q1 net earnings down 258
Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 259
Corporate Communications 261
Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson 261
Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee 262
Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 263
Legal and Regulatory 264
Nov 16, 2017: Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case 264
Nov 01, 2017: Decision Diagnostics CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J 265
Oct 04, 2017: U.S. Supreme Court Turns Back Appeal of $3.27 Million Ethicon Transvaginal Mesh Lawsuit Verdict, Bernstein Liebhard LLP Reports 266
Aug 07, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard Reports 267
Jun 26, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania Mass Tort Program, As Court Schedules July Meeting, Bernstein Liebhard Reports 268
Government and Public Interest 269
Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 269
Product News 270
Apr 05, 2018: Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties 270
Feb 26, 2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology’s Annual Scientific Session 271
Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017 274
Sep 01, 2017: Ethicon Launches New Surgical Simulation Tool, ‘Touch Surgery’, Across EMEA 276
Other Significant Developments 277
Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products 277
Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 278
Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage 279
Appendix 280
Methodology 280
About GlobalData 280
Contact Us 280
Disclaimer 280

List of Tables
Johnson & Johnson, Medical Equipment, Key Facts, 2017 2
Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12
Johnson & Johnson, Medical Equipment Deals By Type, 2012 to YTD 2018 13
Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14
Johnson & Johnson, Deals By Market, 2012 to YTD 2018 15
Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 17
Johnson & Johnson May Sell its Sterilization Products Division for up to USD2 Billion 31
DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 32
Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To US$62 Million 33
OrthoSpin Raises USD3 Million in Financing 34
Cue Health Raises USD45 Million in Series B Venture Financing 35
Zebra Medical Vision Raises USD30 Million in Series C Financing 37
NeuroVision Imaging Raises USD11.2 Million in Series C Venture Financing 38
V-Wave Raises USD70 Million in Series C Financing 40
RefleXion Medical Raises USD100 Million in Series C Financing 42
DayTwo Raises USD12 Million in Series A Financing 44
Hyalex Orthopaedics Raises USD16 Million in Series A Financing 45
CartiHeal Raises USD18.3 Million in Venture Financing 46
Grail Raises USD914 Million in First Tranche of Series B Financing 47
Atlas Genetics Raises USD35 Million in Series D Financing 50
OrthoSpace Raises USD7 Million in Venture Financing 52
ReVision Optics Raises USD32 Million in Venture Financing 53
CVRx Raises USD57.7 Million in Series G Financing 55
RefleXion Medical Raises Additional USD6 Million in Series B Financing 57
WellDoc Raises USD7.5 Million in Extended Series B Financing 58
Cala Health Raises USD18 Million in Series A Financing Round 59
Inivata Raises USD45 Million in Series A Financing 61
V-Wave Raises USD28 Million in Venture Financing 63
CartiHeal Raises USD15 Million in Venture Financing Round 64
Atlas Genetics Raises USD20 Million in Series C Financing 65
La Lumiere Raises USD20 Million in Series B Venture Financing 67
NeuWave Medical Raises USD4.76 Million in Venture Financing 68
Inivata Raises USD6.5 Million in Venture Financing 69
Biocartis Raises USD85 Million in Venture Financing 70
PowerVision Raises USD30 Million in Series D Financing 71
Inspire Medical Systems Raises USD40 Million In Series E Financing 73
Torax Medical Raises US$13.7 Million In Venture Financing 75
Biocartis Raises US$40.5 Million In Series E Financing 76
CVRx Raises US$42 Million In Series F Financing 78
ReVision Optics Raises US$55 Million In Venture Financing 80
Cardiac Dimensions Raises US$2.4 Million In Venture Financing 82
Nevro Raises US$48 Million In Series C Financing 84
Biocartis Raises US$44.7 Million In Series D Financing 86
Torax Medical Raises US$30 Million In Series D Financing 88
NeuWave Medical Raises US$14 Million In Series B Financing 90
Astute Medical Raises US$40.4 Million In Series C Financing 91
Mitralign Raises US$35 Million In Series D Financing 93
Direct Flow Medical Secures USD0.28 Million in Venture Funding 95
Coherex Medical Secures USD16.5 Million in Venture Funding 96
PowerVision Raises Additional US$12.5 Million In Series C Venture Financing 97
Pronota Raises US$4.8 Million In Series C Financing 99
Clarimedix Raises Financing From COSAT 101
Platinum Equity Acquires LifeScan from Johnson & Johnson for USD2.1 Billion 102
Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 103
Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 105
Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 107
Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 108
KFx Medical Enters into Licensing Agreement with DePuy Mitek 109
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 110
Auris Health Enters into Agreement with NeuWave Medical 111
Fujirebio Enters into Agreement with Janssen Pharma 112
Johnson & Johnson Innovation and Johnson & Johnson Vision Care Enter into Partnership with Queensland University of Technology 113
Johnson & Johnson Innovation, Janssen Cilag Enter into Partnership with Queensland University of Technology 114
Johnson & Johnson Innovation and Janssen Pharma Enter into Partnership with MiRXES 115
Johnson & Johnson Vision Care Enters into Partnership with Narayana Nethralaya 116
Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with MiNDERA 117
Genomic Health Enters into Research Agreement with Janssen Pharma 118
DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 119
DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 120
Adaptive Biotech Enters into Partnership with Janssen Biotech 121
Sebia Enters into Agreement with Janssen Biotech 122
Johnson & Johnson Enters into Research Agreement with Orthocell 123
Rest Devices Enters into Agreement with Johnson & Johnson Consumer 124
Aspect Biosystems Partners with DePuy Synthes 125
Karolinska Institutet Partners with Johnson & Johnson Companies 126
WellDoc Enters into Agreement with LifeScan 127
Codman Neuro Enters into Distribution Agreement with InNeuroCo 128
Materialise Enters into Distribution Agreement with DePuy Synthes 129
Johnson & Johnson Services Partners with HP 130
LifeScan Enters into Agreement with WellDoc 131
Biosense Webster Enters into Agreement with Northwestern University 132
Medos International Enters into Agreement with Rainbow Medical 133
Ethicon Endo-Surgery Enters into Agreement with HistoSonics 134
Janssen Pharma Enters into Agreement with Cue 135
Johnson & Johnson Forms Joint Venture with Google Life Sciences 136
DePuy Synthes Enters into Agreement with Radlink 138
Royal Philips Enters into Co-Development Agreement with Janssen Pharma 139
Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 140
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 141
DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 142
Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 143
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 144
Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 145
BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 146
Janssen Research & Development Enters into Research Agreement with MD Biosciences 147
DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 148
Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 149
Myriad Enters Into Research Agreement With Janssen Research & Development 150
DePuy Synthes Expands Co-Marketing Agreement With Brainlab 151
Coherex Medical Enters Into Distribution Agreement With Biosense Webster 152
Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 153
Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 154
OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 155
Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 156
Philips Enters Into Technology Integration Agreement With Biosense Webster 157
DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 158
Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 159
West Pharma Enters Into Co-Development Agreement With Janssen Biotech 160
Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 161
Insulet Enters Into Technology Integration Agreement With LifeScan 162
Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 163
Sphere Medical Completes Private Placement Of Shares For US$5 Million With Johnson & Johnson 164
Johnson & Johnson Completes Public Offering Of Notes Due 2033 For US$650 Million 165
Johnson & Johnson Completes Public Offering Of Notes Due 2018 For US$600 Million 167
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$400 Million 169
Johnson & Johnson Completes Public Offering Of Notes Due 2023 For US$550 Million 171
Johnson & Johnson Completes Public Offering Of Notes Due 2043 For US$500 Million 173
Johnson & Johnson Completes Public Offering Of Notes Due 2016 For US$800 Million 175
CeQur Acquires Assets from Calibra Medical 177
Syncona Acquires Surgical Platform from Janssen Biotech 178
Sinocare May Acquire Diabetes Care Business from Johnson & Johnson for up to USD4 Billion 179
Centinel Spine Acquires Prodisc Assets from DePuy Synthes 180
Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 181
Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 183
Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For US$280 Million 184
Johnson & Johnson To Sell Distal Volar Radius System To Biomet 185
Johnson & Johnson Medical Acquires Emerging Implant Technologies from SHS Gesellschaft 186
Fortive to Acquire Advanced Sterilization Products from Ethicon US for USD2.8 Billion 187
Apsis Acquires Orthotaxy 189
Johnson & Johnson Medical to Acquire Surgical Process Institute 190
Johnson & Johnson Acquires Sightbox 191
Abbott Medical Optics Acquires TearScience 192
Johnson & Johnson Acquires Actelion for USD30 Billion 193
Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 195
Codman Neuro Acquires Neuravi 197
Ethicon Acquires Torax Medical 198
Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 199
Ethicon Endo-Surgery Acquires Megadyne Medical Products 201
Codman Neuro Acquires Pulsar Vascular 202
DePuy Orthopaedics Acquires BioMedical Enterprises 203
Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 204
Johnson & Johnson May Acquire Transenterix 206
Johnson & Johnson Consumer Acquires La Lumiere 207
Biosense Webster Acquires Coherex Medical 208
Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 209
DePuy Synthes Acquires Olive Medical 211
Johnson & Johnson Plans to Acquire Cardiovascular Company 212
ZOLL Medical Acquires CoAxia, Medical Device Company 213
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 215
Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 217
LifeScan Acquires Calibra Medical 218
Johnson & Johnson Completes Acquisition Of Synthes For US$19.7 Billion 219
Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 221
Johnson & Johnson, Key Competitors 222
Johnson & Johnson, Key Employees 223
Johnson & Johnson, Subsidiaries 224

List of Figures
Johnson & Johnson, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Johnson & Johnson, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12
Johnson & Johnson, Medical Equipment, Deals by Type, 2012 to YTD 2018 13
Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14
Johnson & Johnson, Medical Equipment, Deals by Market, 2012 to YTD 2018 15

★海外企業調査レポート[Johnson & Johnson (JNJ):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alimera Sciences Inc (ALIM):医療機器:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Halfords Group plc (HFD):企業の戦略的SWOT分析
    Halfords Group plc (HFD) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Northwest Pipe Co (NWPX):企業の財務・戦略的SWOT分析
    Northwest Pipe Co (NWPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Huawei Technologies Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Huawei Technologies Co., Ltd. (Huawei), a subsidiary of Huawei Investment & Holding Co., Ltd, is an information and communication technology company. The company’s product portfolio includes mobile, broadband, core network, transmission network, and data communication products, besides value …
  • Neurocrine Biosciences Inc (NBIX):製薬・医療:M&Aディール及び事業提携情報
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Cristal Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Cristal Therapeutics BV (Cristal Therapeutics) is a pharmaceutical company that develops nano-medicines for the treatment of cancer and chronic inflammatory disorders. The company develops CriPec docetaxel, a lead product candidate for solid tumours. It also provides peptide-based products, …
  • HanAll Biopharma Co Ltd (009420):製薬・医療:M&Aディール及び事業提携情報
    Summary HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermat …
  • VolitionRX Ltd (VNRX):製薬・医療:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • General Dynamics Information Technology, Inc.:企業の戦略・SWOT・財務情報
    General Dynamics Information Technology, Inc. - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Information Technology, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Daegu Bank Ltd:企業の戦略・SWOT・財務分析
    Daegu Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Daegu Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Avanos Medical Inc (HYH):企業の財務・戦略的SWOT分析
    Summary Avanos Medical Inc (Avanos Medical) is a medical technology company. The company provides medical devices and equipment. It offers clinically-superior products and solutions in digestive health, pain management, infection prevention, surgical solutions and IV therapy. Avanos Medical provides …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • MMX Mineracao e Metalicos SA:企業の戦略・SWOT・財務分析
    MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report Summary MMX Mineracao e Metalicos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Green Plains Inc (GPRE):企業の財務・戦略的SWOT分析
    Green Plains Inc (GPRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • UNIQA Osiguranje d.d.:企業の戦略・SWOT・財務情報
    UNIQA Osiguranje d.d. - Strategy, SWOT and Corporate Finance Report Summary UNIQA Osiguranje d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lantern Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lantern Pharma Inc (Lantern Pharma) is a clinical stage pharmaceutical company that discovers and develops therapies for various cancer types. The company’s pipeline products Irofulven-1 and Irofulven-2 are non-hormone, non-chemotherapy, next-generation DNA damage repair inhibitors. Its othe …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Valeura Energy Inc (VLE):企業の財務・戦略的SWOT分析
    Valeura Energy Inc (VLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆